3Reiffel JA. Drug choices in the treatment of atrial fibrillation[J]. Am J Cardiol ,2000,85 : 12D. 被引量：1
4Reiffel JA. Intravenous amiodarone in the management of atrial fibrillation [ J ]. Pharmacol Ther, 1999,4 : 199. 被引量：1
5Kreiss Y, Sidi Y, Gur H. Efficacy and safety of intravenous amiodarone in recent onset atrial fibrillation:Experience in patients admitted to a general internal medicine department [ J ]. Postgrad Med J, 1999,75 :278. 被引量：1
6Costeas C, Kassotis J, Blitzer M, et al. Rhythm management in atrial fibrillation with a primary emphasis on pharmacological therapy:Part 2[J]. PACE, 1998,21:742. 被引量：1
7Capucci A, Lenzi T, Boriani G, et al. Effectiveness of loading oral flecainide for converting recent onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension[J]. Am J Cardiol,1992,70:69. 被引量：1
8Capucci A, Villani GQ, Piepoli MF, et al. The role of oral lc antiarrhythmic drugs in erminating atrial fibrillation[ J]. Curr Opin Cardiol, 1999,14:4. 被引量：1
9Siniakowicz RM, Narula D, Suster B, et al. Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol, 2001,12:431-436. 被引量：1
10Dusman RE, Staton MS, Miles WM, et al. Clinical features of amiodarone -induced pulmonary toxicity. Circulation,1990, 82:51-59. 被引量：1
